
Uppsala Reports editor
@UMCGlobalSafety
Photo: iStock
Informing patients and the public about risks is tricky. UMC's latest podcast digs into the evidence about what works best, and examines the proper role of health communicators.
People’s perception of risk can vary greatly from person to person, making it challenging for healthcare professionals to communicate benefits and harms of medicines in a balanced fashion.
Alexandra Freeman from the Winton Centre for Risk and Evidence Communication joins the Drug Safety Matters podcast to discuss how to give patients the information they need to decide what's best for them. This fascinating episode challenges assumptions about the role of the narratives in health communication and provides practical, evidence-backed guidance for conveying effective, ethical information about the potential harms and benefits of medicines and vaccines.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
A look back at Sten Olsson’s achievements with UMC and in pharmacovigilance internationally.
Communications / 01 June 2022
If you have a spare couple of minutes, your input can help UMC continue to improve our pharmacovigilance communication methods.
Communications / 14 April 2022
Risks are not just numbers, but feelings. So how do you communicate risks accurately in a way that patients can interpret them? You give them facts, context, and trust.
Communications / 05 July 2022